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This study was conducted to report our experience of intraoperative patient selection for
tubeless percutaneous nephrolithotomy (PCNL) based on a tentative decision-making
algorithm. Thirty-four consecutive patients who were scheduled to undergo tubeless
PCNL were included and medical records were obtained from a prospectively maintained
database for these patients. After completion of PCNL, the nephrostomy site was observed
with a safety guidewire in place. If there was no significant bleeding through the tract,
tubeless PCNL was performed, and in cases with significant bleeding or other
complications, nephrostomy catheter insertion was performed as usual. In 29 cases
(85.3%), tubeless PCNL was performed according to our decision-making protocol. Mean
stone size was 7.33 6 9.35 cm2. Mean hospital stay was 2.61 6 1.01 days. The difference
between preoperative and postoperative hemoglobin was 0.68 6 1.22 g/dL (p . 0.05).
Visual analog pain scale scores immediately post-operation, on postoperative day one and
on the day of discharge were 4.62 6 1.80, 3.25 6 1.68 (postoperative day one vs. operative
day; p ¼ 0.001), and 1.87 6 0.83 (the day of discharge vs. operative day; p ¼ 0.001),
respectively. The success rate with insignificant remnant stones was 85.2% and complete
stone-free rate was 76.5%. In conclusion, tubeless PCNL was performed successfully with
low complication rate and reduced pain score through our decision-making algorithm.
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Currently, percutaneous nephrolithotomy(PCNL) is the treatment of choice for large,
complex renal stones due to low postoperative
morbidity and low complication rate.1,2 Placement
of a nephrostomy catheter is done routinely after
PCNL, as it provides proper drainage of urine,
prevention of urinary extravasation and tamponade
of bleeding.3,4 In addition, it might be used for a
tract for a second-look PCNL.5
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Recently, the need for placement of a nephrosto-
my catheter has been questioned due to an increase
in postoperative discomfort, low incidence of
second-look operation, and increase in morbidity.6,7
Tubeless PCNL has been attempted with proper
drainage of urine through an indwelling antero-
grade stent instead of a nephrostomy tube, or
alternatively without an internal stent at all.8
Tubeless PCNL is not yet widespread despite the
potential benefits of this approach, because there has
been a concern for potentially fatal complications
such as massive bleeding without a nephrostomy
tube.9 Several studies have demonstrated the feasi-
bility of tubeless PCNL for the last two decades;
however, it has not been determined how to choose
patients to undergo either conventional PCNL or
tubeless PCNL. Therefore, this study was conducted
to report our experience of intraoperative patient




From May 2011 to September 2012, 34 consecutive
patients who were scheduled to undergo tubeless
PCNL were included. Before surgery, the desired
calyx was punctured under guidance of fluoroscopy
and a guidewire was inserted by an interventional
radiologist. After that, PCNL was carried out under
Fig. 1 Decision-making algorithm of intra-operative patient selection for tubeless percutaneous nephrolithotomy. AGP: antegrade
pyelography.
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general anesthesia with endotracheal intubation.
The dilatation was performed with a 30 Fr balloon
dilator. After Amplatz sheath insertion, the nephro-
scope was introduced and renal stones were
fragmented using LithoClast.
Patients were selected intra-operatively for tube-
less PCNL based on our decision-making protocol
as follows: after completion of stone removal,
antegrade pyelography (AGP) was performed to
identify significant renal pelvic injury. After removal
of the Amplatz sheath, the nephrostomy site was
carefully observed for 5 to 10 minutes while the
safety guidewire remained in place. If there was no
significant bleeding through nephrostomy site and
no significant injury to the renal pelvis and ureter,
tubeless PCNL was performed. If there were
concerns for either arterial bleeding or massive
venous bleeding, a nephrostomy tube was placed
via the safety guidewire (Figs. 1 and 2).
Pain was evaluated every 8 hours by a trained
nurse using the visual analog scale of pain (VAS).
The patients with moderate to severe pain were
given tramadol, 50 mg IV, or pethidine, 25 mg IM, if
postoperative pain was not controlled with nonste-
roidal analgesics. All patients were monitored by
checking levels of hemoglobin and serum creatinine
pre-operatively and by the seventh postoperative
day. Plain X-ray or abdomen-pelvis computed
tomography was obtained within 1 to 3 months
postoperatively. The patient was discharged when
he or she was thought to be free from complications
Fig. 2 Intra-operative patient selection for tubeless percutaneous nephrolithotomy (PCNL). After completion of stone removal,
antegrade pyelography was performed to identify significant renal pelvic injury (A). After removal of the Amplatz sheath, a
nephrostomy site was carefully observed for 5 to 10 minutes with a safety guidewire in place (B, C). When there is no significant
bleeding through the nephrostomy site and no significant injury to the renal pelvis and ureter, tubeless PCNL was performed (D).
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and when pain was controlled with oral analgesics
(VAS score lower than 3).
Good clinical practice protocols
The study was performed in agreement with
applicable laws and regulations, good clinical
practices, and ethical principles as described in the
Declaration of Helsinki. The Institutional Review
Board of the hospital approved this study protocol
(Approval number: 4-2012-0629).
Statistical analysis
The success rate was defined as the absence of
residual stone fragments under conventional X-ray
or computed tomography or when clinically insig-
nificant residual fragments (CIRF) were observed.
CIRF was defined as residual fragments that were
smaller than 4 mm, asymptomatic, nonobstructive,
and noninfectious.10 Perioperative complications
were evaluated according to the modified Clavien
grading system validated in 2004.11 The preopera-
tive and postoperative VAS pain scores of all
subjects were analyzed by Wilcoxon test. In VAS,
the severity of pain is classified according to a 010
point scale that indicates the degree of pain, where 0
indicates a complete lack of the pain and 10
indicates the most severe pain. Length of hospital
stay was defined as the time interval between the
day of surgery and discharge from the hospital. The
data were analyzed using Open Office.org Calc
(Open Office.org version 3.2.0, Oracle Corp., Red-
wood Shores, CA, USA) and MedCalc (MedCalc
version 11.2.1.0, MedCalc Software, Mariakerke,
Belgium). A P-value less than 0.05 was considered
to be statistically significant.
Results
Following our decision-making protocol, a nephros-
tomy catheter was inserted in 5 cases (14.7%);
significant venous bleeding was suspected in 2
cases, injury of the renal pelvis in 1 case, and
second-look operation was considered in 2 cases. In
29 cases (85.3%), PCNL was completed without
nephrostomy tube placement. The mean age and
body mass index of patients were 53.3 6 18.0 years
and 21.6 6 9.9 kg/m2, respectively. Mean stone size
was 7.33 6 9.35 cm2 (Table 1).
Mean operation time was 89.02 6 46.31 minutes.
Mean hospital stay was 2.61 6 1.01 days. The
difference between preoperative and postoperative
hemoglobin was 0.68 6 1.22 g/dL (P . 0.05). Serum
creatinine level measured preoperatively, on the day
of surgery, and postoperative day one were 1.05 6
0.68 mg/dL, 1.01 6 0.69 mg/dL (operative day one
vs. preoperatively; P ¼ 0.134), and 0.99 6 0.73 mg/
dL (postoperative day one vs. preoperatively; P ¼
0.197), respectively. Visual analog pain scale on the
day of surgery, postoperative day one and the day of
discharge were 4.62 6 1.80, 3.25 6 1.68 (postoper-
ative day one versus operative day; P ¼ 0.011), and
1.876 0.83 (the day of discharge vs. operative day; P
¼ 0.001), respectively.
There were only 4 patients with mild complica-
tions according to the Clavien-Dindo classification
(Grade I in 2 patients and Grade II in 2 patients).
Success rate with CIRF was 85.2% and complete
stone-free rate was 76.5% (Table 2). Five patients
who have significant residual fragments after PCNL
underwent postoperative shock wave lithotripsy,
and 4 patients were successfully treated.
Discussion
According to recent studies, there is no significant
difference between the complications from standard
PCNL and tubeless PCNL.12 It has been reported
that tubeless PCNL was associated with a shorter
hospital stay, a faster return to everyday life, less
pain, and lower cost.13 They recommended that a
nephrostomy catheter should be placed in certain
situations: multiple access, major damage to the
collecting system, possibility of a second look
operation, severe intraoperative bleeding, compli-
Table 1 Preoperative clinical data of patients who underwent tubeless
percutaneous nephrolithotomy
Variables N (%)
Number of patients 34
Male:Female 21:13
Mean age 6 SD 53.35 6 18.00






Staghorn stone 9 (26.47)
Upper calyx and pelvic stone 3 (8.82)
Lower calyx and pelvic stone 13 (38.23)
Lower calyceal stone 6 (17.64)
Renal pelvic stone 3 (8.82)
Mean stone size 6 SD (cm2) 7.33 6 9.35
SD, standard deviation; BMI, body mass index.
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cated cases and intrathoracic trauma.14 However,
tubeless PCNL has not been in widespread use even
considering the potential benefits of this approach,
because there are concerns that potentially fatal
complications such as massive bleeding without a
nephrostomy tube may occur.9 In the case of major
blood vessel damage or severe damage to the
collecting system, a nephrostomy catheter should
be placed. Several studies have demonstrated the
feasibility of tubeless PCNL for the last two decades;
however, there are no guidelines for deciding
between conventional PCNL and tubeless PCNL.
The present study was conducted to report our
experience of intraoperative patient selection for
tubeless PCNL based on a tentative decision-making
protocol. We identified preoperative factors and
postoperative outcomes of tubeless PCNL, and
focused on the issue of patient selection, which
had not been previously examined.
Patients were selected for tubeless PCNL intra-
operatively based on our decision-making algo-
rithm, shown in Figure 1. The key point of this
algorithm is postoperative AGP and careful obser-
vation of the nephrostomy site with a safety guide-
wire in place after completion of PCNL.
Postoperative AGP can show the integrity of the
collecting system, and it can be omitted in many
cases if there is no suspicion of injury to the
collecting system during the operation. Also, the
careful observation of the nephrostomy site with a
safety guidewire in place can make it easier to
determine whether there was significant bleeding
within 5 to 10 minutes. According to our decision-
making protocol, a nephrostomy catheter was
inserted in 5 cases (14.7%), and tubeless PCNL
was performed in 29 cases (85.3%) with minimal
complications. Peri-operative transfusion was re-
quired in only 2 cases (5.8%).
The disadvantages of tubeless PCNL, including
the need to place a ureteral stent, should be also
considered.15 The patient must undergo a cystosco-
py to remove the ureteral stent, and the placement
of a ureteral stent may cause bladder irritation
symptoms such as flank pain, gross hematuria,
urinary frequency, and urgency. Mishra et al
demonstrated that early tube removal after PCNL
resulted in an equivalent analgesic requirement,
decrease in hemoglobin and hospital stay as tubeless
PCNL as well as a significantly lower incidence of
early hematuria, and better clearance.16 Meanwhile,
totally tubeless PCNL can be feasible and is a more
advanced technique compared to early tube remov-
al after PCNL. A meta-analysis by Zhong et al
showed that totally tubeless PCNL is safe and
effective and that it significantly reduced the
hospital stay, analgesic requirement, and the time
to return to normal activity without increased
complications.17 Because this series consists of our
early experiences with tubeless PCNL, we routinely
placed a ureteral stent during tubeless PCNL due to
safety concerns. However, we believe that there is
no need for ureteral stenting if no significant injury
to the collecting system is suspected. Therefore, our
decision-making algorithm can be also applied for
the decision to pursue totally tubeless PCNL.
Omitting the nephrostomy catheter might have
potential risks of bleeding and serious complica-
tions; therefore, there have been attempts to seal the
tract with various alternative methods. Milkahi and
his colleagues introduced instillation of a hemostatic
agent Tiseel into the nephrostomy tract for the first
time.18 However, they were unable to determine if
injection of that agent diminished postoperative
bleeding or urinary extravasation following tubeless
PCNL. Choi et al instilled gel matrix thrombin
(Floseal) in the tract whenever persistent bleeding
was observed after omitting the nephrostomy
catheter.19 Okeke et al explored cryo-ablation of the
nephrostomy tract after tubeless PCNL. They
inserted a cryoprobe into the access tract and
performed a 10-minute freeze-thaw cycle at a
temperature of 200C. This method showed no
significant difference in delayed bleeding or urinary
Table 2 Operative and postoperative outcomes of patients who
underwent tubeless percutaneous nephrolithotomy
Variables P-value
Mean operative time 6 SD (min) 89.02 6 46.31 -
Mean hospital stay 6 SD (day) 2.61 6 1.01 -
Mean change of hemoglobin (g/dL) 0.68 6 1.22 -
Serum creatinine (mg/dL)
Pre-operatively 1.05 6 0.68 -
Operation day 1.01 6 0.69 0.134a
Postoperative day 1 0.99 6 0.73 0.197a
Visual analog pain score
Operation day 4.62 6 1.80 -
Postoperative day 1 3.25 6 1.68 0.001b
Discharge day 1.87 6 0.83 ,0.001b
Clavien-Dindo classification
Grade I 2 -
Grade II 2 -
Success rate (%) 29/34 (85.2) -
Stone-free rate (%) 26/34 (76.5) -
SD, standard deviation.
aVersus preoperative mean creatinine; using Wilcoxon signed
rank test.
bVersus operative day VAS; using Wilcoxon signed rank test.
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extravasation.20 Recently, a randomized study by
Cormio et al showed that TachoSil provided better
tract control and a shorter hospital stay than
nephrostomy tube placement although it did not
reduce pain and analgesic requirements.21 However,
we question whether such agents are needed if
surgeons follow our decision-making protocols,
because in our series, only 2 patients required
perioperative transfusion and our patients had a
mean hospital stay of 2.3 days without the use of
such sealants.
Tubeless PCNL and totally tubeless PCNL are
advocated by leading surgeons in the field of
endourology. The future role of tubed PCNL will
be in cases of severe intra-operative bleeding, major
damage of collecting system, and when there is a
possibility of a second-look operation. However,
there remain some controversies about the feasibil-
ity and efficacy of tubeless PCNL in certain clinical
settings. Shoma et al suggested that the tubeless
approach might not be suitable for patients with
chronic kidney disease or those who require a
supracostal approach through a prospective ran-
domized study.9 But Shah et al reported a successful
outcome using a tubeless technique in a patient with
chronic kidney disease. Sofikerim et al reported that
tubeless PCNL is a safe and effective technique even
after supracostal access and is associated with less
postoperative pain and a shorter hospital stay.22
Resorlu et al maintained that single or no nephros-
tomy drainage following multitract PCNL offered
the potential advantages of decreased postoperative
analgesic requirement, and hospital stay without
increasing the complications.23
To our knowledge, this is the first proposed
decision-making algorithm for intra-operative pa-
tient selection for tubeless PCNL and its feasibility
through our early experiences. However, there are
some limitations regarding selection bias. Most of
our cases were relatively simple and had moderate
stone burdens, and there were no challenging cases
such as those requiring multiple access or supra-
costal access. In addition, this study was not a
randomized controlled trial, and only early experi-
ences were included in the analysis. A large
prospective randomized controlled trial is needed
to confirm our results using our intraoperative
decision-making algorithm for tubeless PCNL.
Conclusions
Tubeless PCNL was successfully performed with a
low complication rate and reduced pain score based
on our intra-operative decision-making algorithm.
A large prospective randomized controlled trial is
needed to confirm our successful early experiences.
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